When does BIMI INTERNATIONAL MEDICAL I (BIMI) report earnings?
BIMI INTERNATIONAL MEDICAL I (BIMI) will report earnings on 2024-11-25.
BIMI INTERNATIONAL MEDICAL I (BIMI) Forecast, Price Target & Analyst Ratings
NASDAQ:BIMI • US05552Q3011
Current stock price
0.31 USD
-0.17 (-35.42%)
At close:
0.3115 USD
+0 (+0.48%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIMI INTERNATIONAL MEDICAL I (BIMI).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $0.31 to mean target of $0.00, Based on 0 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Nov 25, 2024
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 12.84M 7,925.00% | 21.32M 66.04% | 11.83M -44.51% | |
| EBITDA YoY % growth | 5.54M 482.07% | -5.54M -200.00% | -9.73M -75.63% | |
| EBIT YoY % growth | 5.48M 420.47% | -5.78M -205.47% | -9.95M -72.15% | |
| Operating Margin | 42.68% | -27.11% | -84.11% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A